SCHEMBL6921360

SCHEMBL6921360

CCOc1ccc(C(=O)O)c2c3c(oc12)CCCC3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.43
▸ KDM4E B2RXH2 5/20 0.43
▸ RXRA P19793 3/20 0.40
▸ RXRB P28702 2/20 0.40
▸ RXRG P48443 2/20 0.40
▸ HPGD P15428 6/20 0.39
▸ HSD17B10 Q99714 4/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ FHIT P49789 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TSHR P16473 2/20 0.38
▸ MIF P14174 1/20 0.37
▸ TP53 P04637 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8324231 0.89 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL8318915 0.77 NPC1 (0.50) ALDH1A1KDM4EMAPTSMN1; SMN2LMNA
SCHEMBL8319163 0.74 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL8324499 0.73 CNR2 (0.35) —
SCHEMBL5026641 0.73 CYP19A1 (0.47) ALDH1A1KDM4EHPGDHSD17B10L3MBTL1
SCHEMBL8320953 0.73 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL73099 0.72 PTGDR2 (0.44) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL6755376 0.71 GFER (0.50) ALDH1A1KDM4ERXRARXRBRXRG
SCHEMBL8323847 0.71 TSHR (0.37) ALDH1A1KDM4EHPGDHSD17B10L3MBTL1
SCHEMBL72465 0.70 PTGDR2 (0.45) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069831-A1 TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LTD. (US) 2004-08-19 — — WO disclosed
Send feedback